Medanta Share Price
(MEDANTA)
₹1206.4▲4.96%
as on 04:01PM, 20 Feb 2025
Medanta Performance
Day's Low
Day's High
₹1,140Day's Price Range₹1,210.8552 Week's Low
52 Week's High
₹935.552-Week Price Range₹1,511
| Returns % | |
| 1 Month Return | + 14.75 % |
| 3 Month Return | + 7.13 % |
| 1 Year Return | -17.93 % |
| Market Stats | |
| Previous Close | ₹1,149.35 |
| Open | ₹1,143.00 |
| Volume | 8.38L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹30,870.09Cr |
Medanta Key Statistics
P/E Ratio
60.84
PEG Ratio
29.68
Market Cap
₹30,870.09 Cr
P/B Ratio
12.48
EPS
12.16
Dividend Yield
0Sector
Healthcare
ROE
13.52
Medanta Mutual Fund Holdings
Medanta Analyst Rating
based on 15 analysts
66.67%
Buy
20.00%
Hold
13.33%
Sell
Based on 15 analysts offering long term price targets for Medanta. An average target of ₹1271.8
Source: S&P Global Market Intelligence
Medanta Share analysis
Medanta price forecast by 15 analysts
Upside of10.65%
High
₹1470
Target
₹1271.80
Low
₹860
Medanta target price ₹1271.8, a slight upside of 10.65% compared to current price of ₹1206.4. According to 15 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medanta revenue growth forecast
Expected growth rate Q1, FY2027:87.09%
Forecast
Actual
Including amortisation and stock based compensations
Medanta EPS growth forecast
EPS estimate Q1, FY2027:142.60%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Global Health Ltd
Medanta Stock Shows Potential for Recovery - 12 Feb, 2025
Medanta stock has declined over 25% from its highs. A close above Rs 1,200 could trigger a rally, with targets of Rs 1,460 in the next 1-2 months for high-risk traders.Global Health Target Price Increased After Strong Q3 Results - 06 Feb, 2025
Emkay Global Financial has increased Global Health's target price to Rs 1,050 following a 9% beat in Q3FY25 results, driven by strong growth in the developing portfolio. However, challenges remain with bed expansion and margin pressures from the Noida unit.Global Health Reports Strong Q3 Earnings Growth - 05 Feb, 2025
Global Health Ltd (Medanta) reported a 16% increase in Q3 net profit to Rs 143 crore, with revenue rising to Rs 943 crore. EBITDA also showed growth, reflecting strong operational performance.Global Health Reports Strong Q3 Results - 04 Feb, 2025
Global Health Limited, operating Medanta Hospitals, reported a 15.6% increase in PAT to Rs 142.9 crore for Q3 FY25, with revenue up 12.8%. The company also plans to manage a new 110-bed hospital in Ranchi.Emkay Initiates Coverage on Global Health with Caution - 16 Jan, 2025
Emkay has initiated coverage on Global Health Ltd (Medanta) with a 'reduce' rating and a price target of ₹1,000, indicating caution. The firm awaits better entry points as the company navigates delayed project timelines and increasing competition in new markets.
Insights on Global Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 106.29 Cr → 142.91 Cr (in ₹), with an average increase of 13.6% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 43.65% to 43.98% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, MEDANTA stock has moved up by 14.8%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 12.20% to 12.47% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 36.1% return, outperforming this stock by 54.0%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 974.77 Cr → 959.46 Cr (in ₹), with an average decrease of 1.6% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 33.04% to 33.03% in Dec 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 9.59% to 9.00% in Dec 2024 quarter
Medanta Financials
Index Inclusions
Medanta Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.03% | ||
| Foreign Institutions | 12.47% | 2.21 | |
| Mutual Funds | 9% | ||
| Retail Investors | 43.98% | 0.78 | |
| Others | 1.51% |
Medanta Key Indicators
Medanta Valuation
Medanta in the last 5 years
Lowest (37.92x)
April 6, 2023
Today (60.84x)
February 19, 2025
Industry (92.99x)
February 19, 2025
Highest (88.30x)
February 23, 2024
Medanta Earnings and Dividends
Global Health Ltd Earnings Results
Global Health Ltd’s net profit jumped 15.59% since last year same period to ₹142.91Cr in the Q3 2024-2025. On a quarterly growth basis, Global Health Ltd has generated 9.23% jump in its net profits since last 3-months.
Read More about Earnings Results
Medanta Technicals Summary
Bearish
Neutral
Bullish
Global Health Ltd is currently in a Bullish trading position according to technical analysis indicators.
Medanta Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹30,870.09 Cr | 35.35% | 0.55 | ₹326 Cr | ₹2,694 Cr | |
| BUY | ₹45,531.53 Cr | 57.17% | 0.54 | ₹645 Cr | ₹7,175 Cr |
About Medanta
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.
Share Price: ₹1206.40 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹30,870.09Cr as of today
Revenue: ₹943.44Cr as on December 2024 (Q4 24)
Net Profit: ₹142.86Cr as on December 2024 (Q4 24)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
| Organisation | Medanta |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Global Health Ltd
What is Global Health Ltd price today?
Global Health Ltd share price today stands at ₹1206.4, Open: ₹1143, Previous Close: ₹1149.35, High: ₹1210.85, Low: ₹1140, 52 Week High: ₹1511, 52 Week Low: ₹935.5.
How to Buy Global Health Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Global Health Ltd shares
Is Global Health Ltd listed on NSE?
Global Health Ltd is listed on NSE
Is Global Health Ltd listed on BSE?
Global Health Ltd is listed on BSE
What are today's High and Low prices of Global Health Ltd?
- Today's highest price of Global Health Ltd is ₹1210.85.
- Today's lowest price of Global Health Ltd is ₹1140.
What are today's traded volumes of Global Health Ltd?
Today's traded volume of Global Health Ltd(MEDANTA) is 8.38L.
What is today's market capitalisation of Global Health Ltd?
Today's market capitalisation of Global Health Ltd(MEDANTA) is ₹30870.09Cr.
What is the 52 Week High and Low Range of Global Health Ltd?
How much percentage Global Health Ltd is down from its 52 Week High?
Global Health Ltd (MEDANTA) share price is ₹1206.4. It is down -20.16% from its 52 Week High price of ₹1511
How much percentage Global Health Ltd is up from its 52 Week low?
Global Health Ltd (MEDANTA) share price is ₹1206.4. It is up 28.96% from its 52 Week Low price of ₹935.5
What are the historical returns of Global Health Ltd?
What is the PE ratio of Global Health Ltd today?
PE Ratio of Global Health Ltd is 60.84
PE ratio = Global Health Ltd Market price per share / Global Health Ltd Earnings per share